moderate COVID-19 patients

Indian Pharmaceutical Company conducts Clinical Analysis for the Supplement to battle against Post COVID-19 difficulties

ImmunoSEB + ProbioSEB CSC3 for post-resolution of mild to moderate COVID-19 patients Mumbai, Maharashtra [India]: According to recent stats, 2.77…